BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

TASIGNA Pages on BioPortfolio:

Biotechnology News TASIGNA Search
_ FDA Safety Changes: Metronidazole Injection, DexFerrum, INFeD, Tasigna. ... Medscape: Sep 23 2009 8:54PM Matching: tasigna, Find similar documents ...
http://www.bioportfolio.co.uk/TASIGNA-news.htm...

BioPortfolio - Novartis - Video: Tasigna(R) Demonstrates Rapid ...
Novartis - Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia - BioPortfolio - News.
http://www.bioportfolio.com/news/Video:_Tasigna(R)_Demonstra...

Biotechnology News Leukemia Myeloid Aggressive-Phase Search
Novartis Says Tasigna Meets Endpoints Vs. Glivec In Late-stage Leukemia Study - ... Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Tasigna
TASIGNA prolongs the QT interval. Sudden deaths have been reported in patients receiving nilotinib. TASIGNA should not be used in patients with hypokalemia,
...
http://www.bioportfolio.com/indepth/Tasigna.html...

Biotechnology News METRONIDAZOLE Search
FDA Safety Changes: Metronidazole Injection, DexFerrum, INFeD, Tasigna _ FDA Safety Changes: Metronidazole Injection, DexFerrum, INFeD, Tasigna. ...
http://www.bioportfolio.co.uk/METRONIDAZOLE-news.htm...

BioPortfolio News: Novartis - Novartis drug Tasigna(R) meets ...
Novartis - Novartis drug Tasigna(R) meets primary... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/Novartis-drug-Tasigna(R)-me...

Biotechnology News GLEEVEC Search
Tasigna produced faster and deeper responses compared to Gleevec as first-line treatment in ... _ Novartis' Tasigna Seen Succeeding Top Drug Gleevec. ...
http://www.bioportfolio.co.uk/GLEEVEC-news.htm...

BioPortfolio - Chromosome Aberrations
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in ... TASIGNA prolongs the QT interval. Sudden deaths have been reported in patients ...
http://www.bioportfolio.com/indepth/Chromosome_Aberrations.h...

Biotechnology News STIE-CORT Search
4 Nov 2009 ... Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec (R) as first-line treatment in chronic myeloid leukemia ...
http://www.bioportfolio.co.uk/STIE-CORT-news.htm...

BioPortfolio - Leukemia Adult Chronic - InDepth
Novartis drug Tasigna meets primary endpoint in pivotal trial against Glivec as ... Novartis Says Tasigna Meets Endpoints Vs. Glivec In Late-stage Leukemia ...
http://www.bioportfolio.com/indepth/Leukemia_Adult_Chronic.p...

Results from other life science and pharmaceutical sites:

2 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...
Tasigna prolongs the QT interval (5.2). Sudden deaths have been reported in patients receiving nilotinib (5.3). Tasigna should ...
http://www.pharma.us.novartis.com/product/pi/pdf/tasigna.pdf...

Nilotinib - Wikipedia, the free encyclopedia
It was approved as Tasigna in the USA and the EU for drug-resistant chronic ... "FDA Approves Tasigna for Treatment of Philadelphia Chromosome Positive ...
http://en.wikipedia.org/wiki/Nilotinib...

Novartis drug Tasigna® meets primary endpoint in pivotal trial ...
20 Oct 2009 ... Tasigna produced faster and deeper responses compared to Glivec as first-line treatment in Philadelphia chromosome-positive chronic myeloid ...
http://www.novartis.com/newsroom/media-releases/en/2009/1348...

FDA Safety Changes: Metronidazole Injection, DexFerrum, INFeD, Tasigna
23 Sep 2009 ... The FDA has approved safety labeling revisions for metronidazole injection, iron dextran injection (DexFerrum and INFeD), and nilotinib HCl ...
http://www.medscape.com/viewarticle/709381...

Tasigna® gains European approval for patients with a life ...
28 Nov 2007 ... Basel, November 28, 2007 - Tasignaâ (nilotinib) has received European Union approval as a new anti-cancer therapy for patients with a ...
http://www.novartis.com/newsroom/media-releases/en/2007/1171...

Tasigna (nilotinib) capsules
15 Sep 2009 ... Tasigna (nilotinib) capsules Drug Safety Labeling Changes August 2009 MedWatch.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm1822...

Tasigna® demonstrates rapid response as initial therapy in life ...
8 Dec 2008 ... Tasigna now shows potential to become the treatment of choice for certain newly diagnosed patients with chronic myeloid leukemia ...
http://www.novartis.com/newsroom/media-releases/en/2008/1275...

FDA Approves Tasigna for Treatment of Philadelphia Chromosome ...
30 Oct 2007 ... The US Food and Drug Administration (FDA) has approved Tasigna (nilotinib) capsules for treatment of Philadelphia chromosome positive ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...

TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication ...
Read this Medication Guide before you start taking Tasigna ... What is the most important information I should know about Tasigna? ...
http://www.pharma.us.novartis.com/product/pi/pdf/tasigna_pmg...

Tasigna® shows rapid and deep responses in newly diagnosed ...
5 Jun 2009 ... Basel, June 5, 2009 - New data show that at 12 months newly diagnosed patients taking Tasigna® (nilotinib) to treat a life-threatening form ...
http://www.novartis.com/newsroom/media-releases/en/2009/1320...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.